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Purpose: High myopia is a severe hereditary ocular disease leading to blindness. LAMA1 (alpha subunit of laminin) is a
promising candidate gene for high myopia present in the MYP2 (myopia 2) region. The purpose of this study was to
determine if high myopia is associated with single nucleotide polymorphism (SNP) variants in LAMA1 in Chinese subjects.
Methods: Ninety-seven Chinese subjects with high myopia and ethnically and sexually matched 103 normal controls
were enrolled. Genomic DNA was prepared from peripheral blood. The 5 SNPs of LAMA1 were analyzed using PCR and
SNaPshot. Allele frequencies were tested for Hardy–Weinberg disequilibrium. The genotype and allele frequencies were
evaluated using the χ2 tests or the Fisher exact tests.
Results:  One  of  the  5  SNPs  showed  a  significant  difference  between  patients  and  control  subjects  (rs2089760:
pgenotype=0.005, pallel=0.003). There were no statistically significant differences between patients and control subjects for
the other four SNPs: rs566655, rs11664063, rs607230, and rs3810046.
Conclusions: Our results indicate that the polymorphism of rs2089760, located in the promoter region of LAMA1, may
be associated with high myopia in the Chinese population and should be investigated further.
Myopia is a significant public health problem worldwide,
with the highest prevalence in East Asians. The Handan eye
study [1] showed the prevalence rate of myopia and high
myopia (myopia in excess of 6 diopters [D])in a rural Chinese
adult population was 26.7% and 1.8% separately, and a study
of the Singapore adult Chinese population [2] showed the
prevalence rate of myopia and high myopia was 38.7% and
9.1% separately. High myopia can cause blindness or a severe
loss of visual acuity due to retinal detachment, submacular
hemorrhage, glaucoma or macular degeneration [3], and 30%
to 70% of high myopia display at least some lesions of the
retina  and  choroids  [4].  However,  effective  treatment
methodology and preventive strategies for high myopia have
not yet been fully established. Therefore, it is important to
identify the etiology of high myopia.
Myopia  is  a  complex  disease  involving  multiple
interacting  genetic  and  environmental  factors.  Studies  of
twins provide the most compelling evidence that myopia is
inherited. Multiple studies note an increased concordance of
refractive error and refractive components (corneal curvature,
lens power, anterior chamber depth) in monozygotic twins
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compared with dizygotic twins [5,6]. Twin studies estimate a
notable  heritability  value  (the  proportion  of  the  total
phenotypic  variance  that  is  attributed  to  the  genome)  of
between 0.5 and 0.96 [7].
In 1998, Young [8] performed a linkage analysis of eight
families  with  high  myopia  in  two  or  three  successive
generations, containing a total of 82 individuals to obtain the
maximum  lod  score  of  9.59  for  the  microsatellite  marker
D18S481. This region, which mapped at 7.6 cM on the short
arm of chromosome 18 (18p11.31, MYP2 [myopia 2]), was
indicated to be a susceptibility genetic locus for high myopia.
Additionally, the MYP2 locus has been confirmed by two
outside  laboratories:  an  Italian  patient  population  with
autosomal dominant high myopia by Heath and colleagues
[9] and six families of Hong Kong Chinese descent by Lam
and colleagues [10]. All genes that map within the MYP2
critical region are candidate disease genes based on position.
Coding  regions,  intron-exon  boundaries  and  untranslated
exons  of  Clusterin-like  1  (CLUL1),  elastin  microfibril
interfacer  2  (EMILIN2),  lipin  2  (LPIN2),  myomesin  1
(MYOM1), myosin regulatory light chain 3 (MRCL3), myosin
regulatory light chain 2 (MRLC2), transforming growth β-
induced factor (TGIFβ), large Drosophila homolog associated
protein 1 (DLGAP1), and zinc finger protein 161 homolog
(ZFP161)  were  sequenced,  but  mutation  analysis  did  not
identify sequence alterations associated with high myopia
[11]. The direct analysis of sequence within a critical region
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1003can be the most accurate, precise and efficient approach to
disease  gene  identification.  But  susceptibility  loci
contributing to high myopia may be difficult to map by classic
linkage analysis because of the limited power to detect genes
of intermediate or small effect using independent pedigrees.
Currently, genetic association studies are regarded as the most
powerful approach to mapping of the genes underlying such
complex traits [12]. And TGIF has been implicated as the
MYP2-causative  gene  by  single  nucleotide  polymorphism
(SNP) association studies [13], but has not been replicated in
a second Chinese case– control study [14] and a Japanese
case– control study [15].
The  identification  of  the  MYP2  gene  will  not  only
provide insight into the molecular basis of high myopia, but
will also identify pathways that are involved in eye growth
and development. In addition, this information may implicate
other  genes  as  possible  myopia  disease  gene  candidates.
Among all the MYP2 genes, laminin α chain (LAMA1) is a
biologically  relevant  candidate  gene,  since  laminin  is  a
component of a structural glycoprotein found in the ocular
scleral wall. Laminin is present in the eye as a constituent of
the elastic system in the trabecular meshwork [16] and zonular
(oxytalan) fibers of the lens [17]. It has also been identified in
the  astrocytic  and  vascular  endothelial-cell  basement
membranes of the laminar-beam margins of the rodent lamina
cribosa  [18].  Marshall  [19]  has  localized  laminin  to  the
oxytalan  and  elaunin  microfibrils  of  human  sclera  by
immunoelectron  microscopy.  These  microfibrils  comprise
two of the three components of the elastic-fiber system that
make elastic tissue more stretchable than collagen [20,21].
Marshall suggests that laminin may bind these microfibrils to
collagen fibrils, since laminin has been shown to have binding
sites for several extracellular matrix components, including
collagen [22]. LAMA1 gene was reported to be located at the
short arm of chromosome 18 [23], approximately 1,648 kb
centromeric  of  the  ZFP161  gene  in  the  MYP2  region,
LAMA1 attracts our attention as a promising candidate gene
for high myopia. Recently, we found the mRNA level of
LAMA1 was lower in high myopic scleral tissue than in non-
myopic scleral tissue through testing the transcriptional level
(mRNA level) of LAMA1 in scleral tissue [24].
Here,  to  further  investigate  the  correlation  between
LAMA1 and high myopia, we conducted a case-control study
to analyze the SNPs of LAMA1 for association with high
myopia.
METHODS
Subjects: A total of 97 patients were enrolled: 39 males, 58
females; mean age of 40.4±12.3 years; refractive error: −6.00
D or more negative and ocular axial lengths: more than 26 mm
for both eyes. One hundred-three unrelated control subjects
were enrolled: 43males, 60 females; mean age of 45.8±13.5
years; refractive errors: −1.00 D to 1.00D and ocular axial
lengths: 22 mm to 24 mm for both eyes. Auto refraction (auto
keratometer,  ARK  700A;  Topcon,  Tokyo,  Japan)  was
performed  on  both  eyes  of  each  patient  by  experienced
optometrists  who  were  trained  and  certified  in  the  study
protocols. Corneal curvature (average of K1 and K2), anterior
chamber depth (ACD)and axial length measurements were
presented  in  Table  1.  Comprehensive  ophthalmic
examinations  were  performed,  and  blood  samples  were
collected from all patients. None of the participants had a
history of ocular disease or ocular insult that may affect an
individual’s refraction, such as retinopathy of prematurity or
neonatal ocular problems or a genetic disease or connective
tissue disorder associated with myopia, such as Stickler or
Marfan  syndrome.  Clinical  examination  included  visual
acuity,  refractive  error,  slit  lamp  examination,  ocular
movements, intraocular pressure, and fundus examination.
Patients with organic eye disease; a history or evidence of
intraocular surgery; and/or a history of cataract, glaucoma,
retinal disorders, or laser treatment were excluded.
TABLE 1. REFRACTION STATUS AND OCULAR BIOMETRIC MEASURES OF PARTICIPANTS.
Characteristics Patients Control
  Right eye Left eye Right eye Left eye
K1 (mm) (Mean) 7.83 7.82 7.75 7.74
Std. 0.36 0.33 0.24 0.23
K2 (mm) (Mean) 7.59 7.60 7.57 7.60
Std. 0.35 0.32 0.24 0.24
ACD (mm) (Mean) 3.51 3.52 3.11 3.12
Std. 0.44 0.45 0.45 0.46
Axial length (mm) (Mean) 29.79 29.69 23.19 23.24
Std. 2.97 2.91 0.59 0.62
spherical equivalent (D) (Mean) −13.81 −13.07 −0.47 −0.13
Std 6.10 5.63 0.54 −0.69
        ACD: anterior chamber depth ; K: keratometry value (K1 the power in the meridian with greatest curvature and K2 the power
        in the meridian perpendicular to it).
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1004This  study  was  approved  by  the  ethics  committee  of
Dalian  Medical  University,  Dalian,  China,  and  informed
consent  was  obtained  from  all  patients.  The  study  was
performed  according  to  the  tenets  of  the  Declaration  of
Helsinki for research involving human subjects.
DNA extraction: Total genomic DNA was extracted from 10
to 15 ml of venous blood from all participants, after informed
consent was obtained. DNA was purified from lymphocyte
pellets according to standard procedures using a kit (Puregene
kit; Gentra Systems, Minneapolis, MN).
SNP selection: We used the NCBI dbSNP database to extract
the available information of the SNPs in LAMA1. SNPs were
selected  using  criteria  such  as  population-frequency
validation, multiple submitters and high-profile submitters.
The most important criteria was selecting those likely to alter
LAMA1 transcription or translation. So we focused on the
SNPs located in exons or 5′-flanking or UTR regions. A total
of 5 SNPs used in this study were: rs2089760 in the 5′-flanking
region,  rs566655  in  exon  14,  rs11664063  in  exon  39,
rs607230 in exon 42, and rs3810046 in the 3′-flanking region.
Analysis  of  LAMA1  polymorphisms:  Single  nucleotide
polymorphisms  (SNPs)  were  determined  by  multiplex
SNaPshot  technology  (according  to  previously  described
methods  [25-27],  using  an  ABI  fluorescence-based  assay
allelic discrimination method (Applied Biosystems, Bedford,
MA).The  primers  for  polymerase  chain  reaction  (PCR)
amplification (shown in Table 2) and SNaPshot extension
reactions (shown in Table 2) were both designed to be aligned
with the NCBI sequence databases using Primer3 software.
The extension primer was designed to anneal immediately
adjacent to the nucleotide at the mutation site, either on the
sense or antisense DNA strand. PCR was performed in a total
volume of 10 μl containing 1× HotStarTaq buffer 1 μl, 3.0 mM
Mg2+, 0.3 mM each of dATP, dCTP, dTTP, and dGTP, 1 U
HotStarTaq  polymerase  (Qiagen,  Chatsworth,  CA),  1  μl
genomic DNA, and 1 μl of each primer. The samples were put
through 30 to 40 cycles of denaturation at 95 °C, annealing at
specific primer temperatures, elongation at 72 °C, and a final
extension at 72 °C. The PCR product was purified by 1 U SAP
and  1  U  Exonuclease  I.  The  product  was  then  processed
according  to  the  ABI  SNaPshot  protocol.  Extension  was
performed in a total volume of 10 μl containing 5 μl SNaPshot
Multiplex Kit (ABI), 2 μl PCR product,1 μl mixed extension
primer and 2 μl H2O. The samples were put through 28 cycles
of denaturation at 96 °C, annealing at 50 °C, elongation at
60 °C, and a final extension at 72 °C. The extension product
was purified by 1 U SAP (shrimp alkaline phosphatase). SNP
analysis was performed using an ABI3130 genetic analyzer.
Genotypes  were  determined  automatically  using
Genemapper4.0 software (Applied Biosystems).
Statistical analysis: We evaluated the allele frequencies of
sequence alterations in patients and controls using the χ2 tests
or the Fisher exact tests. All detected SNPs were assessed for
Hardy–Weinberg disequilibrium using the χ2 test. Statistical
analyses  were  performed  on  computer  using  the  SPSS
TABLE 2. LAMA1 SEQUENCE VARIANTS AND PCR AND EXTENSION PRIMERS.
RefSNP
    ID
SNP Property Base Pair
Change
Amino acid
Change
PCR primer
rs2089760 5′-flanking G>A / F: TGCATCCTTTTAAAACGGCCAAA         
R:TTTCCTCTCACTTGTGTGAATCTATTTGA
rs566655 non-synon (exon 14) A>C p.Asn674Thr F:CGTGACCAGCTGATGACTGTCC
        R:CAATACATACCTGTAAAGAGCCATTTTTGC 
rs11664063 non-synon exon 39) G>A p.Ala1876Thr F:GTCTGCCAAAATCAGGCACCAC
        R:TTCCCACAAAGGCGTGTTCCTA
rs607230 non-synon exon 42) A>G p.Lys2002Glu F:CCAGGCAAACCAATGAATCACTC
        R:CCTTTGCAAGTAAAAATTTTGCCAATC
rs3810046 3′-flanking A>C / F:TCCAATTTCTACAACAGACAAGCAATG
       
R:TGCAAAATGCGCTGTTAGGTGA
Extension primer
rs2089760 SR TTTTGTGTGAATCTATTTGACAACTCTATCAATT
rs566655 SF TTTTTTTTTTTTTTTTTTTTTTGACACATCTTTTGATCAGAGCCA
rs11664063 SF CAGAGCTGAGGACCATGCC
rs607230 SR AGAAGAAAGTCCTTTCCACTTACCTT
rs3810046 SF TTTTTTTTTTTTTTTTTTTTTTCAGACAAGCAATGTTCATTGATTAATT
             Rs:public reference SNP number from the dbSNP database; p: protein; non-synon: Non-Synonymous.
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1005software  (version  13.0;  SPSS  Science,  Chicago,  IL).The
statistical between-group differences were examined using
the respective allele models of dominant and recessive. A
p<0.05  was  considered  statistically  significant.  The  more
powerful  false  discovery  rate  (FDR)  [28],  instead  of  the
conventional Bonferroni procedure, was used to control for
multiple  hypothesis  testing.  Odds  ratios  (ORs)  were
calculated from genotype and allelic frequencies with a 95%
confidence interval (CI).
RESULTS
We screened 5 SNPs within LAMA1 for all the cases and
controls  (Figure  1).  No  deviations  from  Hardy–Weinberg
equilibrium  were  observed  (Table  3).The  genotype
distributions and allele frequencies of the five polymorphisms
were shown in Table 3. Comparison of the genotypes between
individuals with high myopia and the control group revealed
no  significant  difference  for  four  of  five  polymorphisms,
including rs566655, rs11664063, rs607230, and rs3810046.
However,  one  polymorphism  in  the  5′-flanking  region
(rs2089760)  showed  significant  difference  between  the
patients and the controls (Genotype: p=0.005; Allele: p=0.003
and  OR:  1.378).  After  FDR  correction,  they  were  still
significant (Genotype: p=0.033; Allele: p=0.03).
In relation to the two types of alleles that are present at
each SNP (allele 1 and allele 2), statistical between-group
differences  were  examined  using  their  respective  allele
models of dominant and recessive (shown in Table 4). For
Allele1 recessive model (that allele 1 is present on both of the
two homologous chromosomes, ie, in this model the disease
does not occur unless homozygous for allele 1, this is implied
to be also a dominant model for allele 2) only rs2089760
showed significant difference between the patients and the
controls (p=0.002, after FDR correction p=0.04). For Allele1
dominant model (that allele 1 is present on either of the two
homologous chromosomes, in this model the onset of disease
occurs even when heterozygous for allele 1, this is implied to
be also a recessive model for allele 2) no significant difference
for the five SNPs.
DISCUSSION
The  sclera,  the  tough  outer  coat  of  the  eye,  is  a  typical
connective tissue that provides the structural framework for
the eye. The sclera comprises extracellular matrix (ECM) and
matrix secreting fibroblasts. It is arranged in layers (lamellae)
that may play an important role in controlling the size of the
eye. The extracellular matrix of the sclera has been shown to
contain  collagen  fibrils  in  close  association  with
proteoglycans and glycoproteins [29]. Alterations in any of
these extracellular matrix components are likely to lead to
changes in eye shape. Studies have shown that the scleral
extracellular  matrix  undergoes  significant  changes  during
growth and aging [30] and is dramatically altered during the
development of myopia [31,32]. Many of the pathological
changes seen in highly myopic human eyes are a consequence
of gross scleral thinning, particularly at the posterior pole of
Figure 1. Multiplex SNaPshot analysis of 5 SNPs of LAMA1. Arrow: a heterozygote for the rs2089760 polymorphism.
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1008the eye [33]. It is presumed that a blurred image or light
projected onto the retina induces secretion of some substance
from cells, which evokes transfer of the signal to the sclera,
thus leading to sclera remodeling. Laminin is a glycoprotein
of  900  kDa  with  multiple  domain  structures.  Its  three
component chains, α, β, and γ are bonded to each other with
the  α  chain  being  in  the  central  region  and  they  form  a
cruciform  structure  [34].  Laminin  is  a  component  of  an
extracellular matrix protein that binds microfibrils to collagen
fibrils, so LAMA1 is a biologically relevant MYP2 candidate
gene. And LAMA1 maps to the18p11.31 region, its genome
size is 175,928 bp composed of 62 exons, and the mRNA size
of LAMA1 is 9,530 bp encoding 3,075 amino acids [35,36].
While Sayaka Sasaki’s research in 2007 [37] found no
statistically appreciable differences through analysising 13
SNPs of LAMA1 through association study. But, we found
their  controls  including  cases  with  moderate  myopia
(refractive error weaker than −4.0 D), we thought it may
influence the consequence. While our entry criteria was strict:
patients with <−6.00 diopters for both eyes and ocular axial
lengths of >26 mm for both eyes, controls with refractive
errors of >-1.00 and <1.00 diopters for both eyes and ocular
axial  lengths  of  >22  mm  and  <24  mm  for  both  eyes.
Furthermore, we selected the cases with the normal corneal
curvature [38,39] and ACD [40] to entry our study, which can
exclude those non-axial length high myopia. And 13 SNPs in
the study of Sayaka Sasaki [37] did not include 4 of 5 SNPs
in our study, except rs11664063. For rs11664063, we found
the genotype and the allele frequencies of patients in our study
were similar with theirs (Sayaka Sasaki [37] study: (allele
frequencies) G 86.2%/A13.8%; (genotype frequencies) GG
74.3%/AG 23.9%/AA1.8%). But the genotype frequencies of
controls were much more different (our study: AA 2.9%/AG
32%/GG 65%; Sayaka Sasaki [37] study: AA 3.1%/AG 22%/
GG  74.9%),  we  think  the  discrepancy  maybe  due  to  the
different selection criteria for control subjects in our study.
Thus, population differences between the two studies may
have contributed to the difference in the result.
In their study [37], they selected the13 SNPs ensuring
their wide distribution over the regions ranging from exon 1
to 62, but actually the 13 SNPs didn’t reflect the relations
between  high  myopia  and  all  polymorphisms  in  LAMA1.
Thus,  they  suggested  more  detailed  SNPs  analysis  in
LAMA1 may be necessary for the complete screen of the entire
LAMA1 gene. While, we selected our 5 SNPs based on in-
depth study of the functions of LAMA1 SNPs and focused on
those likely to alter LAMA1 gene transcription or translation.
We  used  the  AliBaba2.1  software  to  predict  the  putative
regulatory elements in the LAMA1 promoter region. The result
showed a 2,000 bp promoter region contains several putative
transcription factor binding sites, such as Oct-1 (octamer-1),
Sp-1 (specificity protein 1), NF-1 (nulear factor 1), C/EBPalp
(CCAAT/enhancer  binding  protein  alpha),  NF-kappaB
(Nuclear  Factor-KappaB),  AP-2alpha  (transcription  factor
activator protein alpha), c-Jun, and AP-1 (activator protein 1).
And rs2089760 just locates at a C/EBPalp element binding
site   (at   −1,142  bp   upstream   from  the  transcription
initiation) which indicates this polymorphism may influence
transcriptional efficiency.    
In conclusion, our results indicate that the polymorphism
of rs2089760, located in the promoter region of LAMA1, may
be associated with high myopia in Chinese population and
should be investigated further.
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